Sequential hemibody and local irradiation with combination chemotherapy for small cell lung carcinoma

A preliminary analysis

Bayard L. Powell, Don V. Jackson, Charles W. Scarantino, Ellen Pope, Robert Choplin, Johnny B. Craig, James N. Atkins, M. Robert Cooper, Judith O. Hopkins, Renee McMahan, Hyman B. Muss, Frederick Richards, John J. Stuart, Douglas R. White, Patricia Zekan, Charles L. Spurr, Robert L. Capizzi

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Sequential hemibody irradiation (SHB) was integrated with combination chemotherapy and local irradiation (LRT) in the induction and consolidation phases of a therapeutic protocol for small cell lung carcinoma (SCLC). Forty-one previously untreated patients were entered into this program. Among 38 evaluable patients (20 with limited disease [LD] and 18 with extensive disease [ED], the overall response rate was 63% (90% in LD and 33% in ED patients). The estimated overall survival is 8.1 months. The major toxicity has been myelosuppressione-specially thrombocytopenia. The frequency of previously described "acute radiation syndromes" and radiation pneumonitis associated with hemibody irradiation have been substantially decreased at the current dosage with premedication and shielding techniques. The integration of SHB as a systemic therapy with combination chemotherapy and LRT is a feasible program for sequential administration of non-cross-resistant agents in SCLC and may be beneficial in patients with limited disease.

Original languageEnglish (US)
Pages (from-to)457-462
Number of pages6
JournalInternational Journal of Radiation Oncology Biology Physics
Volume11
Issue number3
DOIs
StatePublished - 1985
Externally publishedYes

Fingerprint

Hemibody Irradiation
Small Cell Lung Carcinoma
chemotherapy
Combination Drug Therapy
lungs
cancer
irradiation
Acute Radiation Syndrome
Radiation Pneumonitis
Premedication
consolidation
radiation
toxicity
Thrombocytopenia
shielding
therapy
induction
dosage
Survival
Therapeutics

Keywords

  • Chemotherapy
  • Half-body irradiation
  • Hemibody irradiation
  • Lung cancer
  • Small cell lung cancer

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation

Cite this

Sequential hemibody and local irradiation with combination chemotherapy for small cell lung carcinoma : A preliminary analysis. / Powell, Bayard L.; Jackson, Don V.; Scarantino, Charles W.; Pope, Ellen; Choplin, Robert; Craig, Johnny B.; Atkins, James N.; Cooper, M. Robert; Hopkins, Judith O.; McMahan, Renee; Muss, Hyman B.; Richards, Frederick; Stuart, John J.; White, Douglas R.; Zekan, Patricia; Spurr, Charles L.; Capizzi, Robert L.

In: International Journal of Radiation Oncology Biology Physics, Vol. 11, No. 3, 1985, p. 457-462.

Research output: Contribution to journalArticle

Powell, BL, Jackson, DV, Scarantino, CW, Pope, E, Choplin, R, Craig, JB, Atkins, JN, Cooper, MR, Hopkins, JO, McMahan, R, Muss, HB, Richards, F, Stuart, JJ, White, DR, Zekan, P, Spurr, CL & Capizzi, RL 1985, 'Sequential hemibody and local irradiation with combination chemotherapy for small cell lung carcinoma: A preliminary analysis', International Journal of Radiation Oncology Biology Physics, vol. 11, no. 3, pp. 457-462. https://doi.org/10.1016/0360-3016(85)90175-0
Powell, Bayard L. ; Jackson, Don V. ; Scarantino, Charles W. ; Pope, Ellen ; Choplin, Robert ; Craig, Johnny B. ; Atkins, James N. ; Cooper, M. Robert ; Hopkins, Judith O. ; McMahan, Renee ; Muss, Hyman B. ; Richards, Frederick ; Stuart, John J. ; White, Douglas R. ; Zekan, Patricia ; Spurr, Charles L. ; Capizzi, Robert L. / Sequential hemibody and local irradiation with combination chemotherapy for small cell lung carcinoma : A preliminary analysis. In: International Journal of Radiation Oncology Biology Physics. 1985 ; Vol. 11, No. 3. pp. 457-462.
@article{7ff85c56608b48bebb577f7781d76da4,
title = "Sequential hemibody and local irradiation with combination chemotherapy for small cell lung carcinoma: A preliminary analysis",
abstract = "Sequential hemibody irradiation (SHB) was integrated with combination chemotherapy and local irradiation (LRT) in the induction and consolidation phases of a therapeutic protocol for small cell lung carcinoma (SCLC). Forty-one previously untreated patients were entered into this program. Among 38 evaluable patients (20 with limited disease [LD] and 18 with extensive disease [ED], the overall response rate was 63{\%} (90{\%} in LD and 33{\%} in ED patients). The estimated overall survival is 8.1 months. The major toxicity has been myelosuppressione-specially thrombocytopenia. The frequency of previously described {"}acute radiation syndromes{"} and radiation pneumonitis associated with hemibody irradiation have been substantially decreased at the current dosage with premedication and shielding techniques. The integration of SHB as a systemic therapy with combination chemotherapy and LRT is a feasible program for sequential administration of non-cross-resistant agents in SCLC and may be beneficial in patients with limited disease.",
keywords = "Chemotherapy, Half-body irradiation, Hemibody irradiation, Lung cancer, Small cell lung cancer",
author = "Powell, {Bayard L.} and Jackson, {Don V.} and Scarantino, {Charles W.} and Ellen Pope and Robert Choplin and Craig, {Johnny B.} and Atkins, {James N.} and Cooper, {M. Robert} and Hopkins, {Judith O.} and Renee McMahan and Muss, {Hyman B.} and Frederick Richards and Stuart, {John J.} and White, {Douglas R.} and Patricia Zekan and Spurr, {Charles L.} and Capizzi, {Robert L.}",
year = "1985",
doi = "10.1016/0360-3016(85)90175-0",
language = "English (US)",
volume = "11",
pages = "457--462",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Sequential hemibody and local irradiation with combination chemotherapy for small cell lung carcinoma

T2 - A preliminary analysis

AU - Powell, Bayard L.

AU - Jackson, Don V.

AU - Scarantino, Charles W.

AU - Pope, Ellen

AU - Choplin, Robert

AU - Craig, Johnny B.

AU - Atkins, James N.

AU - Cooper, M. Robert

AU - Hopkins, Judith O.

AU - McMahan, Renee

AU - Muss, Hyman B.

AU - Richards, Frederick

AU - Stuart, John J.

AU - White, Douglas R.

AU - Zekan, Patricia

AU - Spurr, Charles L.

AU - Capizzi, Robert L.

PY - 1985

Y1 - 1985

N2 - Sequential hemibody irradiation (SHB) was integrated with combination chemotherapy and local irradiation (LRT) in the induction and consolidation phases of a therapeutic protocol for small cell lung carcinoma (SCLC). Forty-one previously untreated patients were entered into this program. Among 38 evaluable patients (20 with limited disease [LD] and 18 with extensive disease [ED], the overall response rate was 63% (90% in LD and 33% in ED patients). The estimated overall survival is 8.1 months. The major toxicity has been myelosuppressione-specially thrombocytopenia. The frequency of previously described "acute radiation syndromes" and radiation pneumonitis associated with hemibody irradiation have been substantially decreased at the current dosage with premedication and shielding techniques. The integration of SHB as a systemic therapy with combination chemotherapy and LRT is a feasible program for sequential administration of non-cross-resistant agents in SCLC and may be beneficial in patients with limited disease.

AB - Sequential hemibody irradiation (SHB) was integrated with combination chemotherapy and local irradiation (LRT) in the induction and consolidation phases of a therapeutic protocol for small cell lung carcinoma (SCLC). Forty-one previously untreated patients were entered into this program. Among 38 evaluable patients (20 with limited disease [LD] and 18 with extensive disease [ED], the overall response rate was 63% (90% in LD and 33% in ED patients). The estimated overall survival is 8.1 months. The major toxicity has been myelosuppressione-specially thrombocytopenia. The frequency of previously described "acute radiation syndromes" and radiation pneumonitis associated with hemibody irradiation have been substantially decreased at the current dosage with premedication and shielding techniques. The integration of SHB as a systemic therapy with combination chemotherapy and LRT is a feasible program for sequential administration of non-cross-resistant agents in SCLC and may be beneficial in patients with limited disease.

KW - Chemotherapy

KW - Half-body irradiation

KW - Hemibody irradiation

KW - Lung cancer

KW - Small cell lung cancer

UR - http://www.scopus.com/inward/record.url?scp=0021911771&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021911771&partnerID=8YFLogxK

U2 - 10.1016/0360-3016(85)90175-0

DO - 10.1016/0360-3016(85)90175-0

M3 - Article

VL - 11

SP - 457

EP - 462

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 3

ER -